Drug comparisons
Canagliflozin vs Troglitazone
Canagliflozin vs Troglitazone for diabetes: SGLT2 vs TZD. Troglitazone withdrawn due to hepatotoxicity. Compare mechanisms, safety, and availability.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when evaluating modern SGLT2 inhibitors against historical thiazolidinediones withdrawn for safety in type 2 diabetes care.
Bottom line
Canagliflozin is the only currently viable option of the two due to Troglitazone's market withdrawal.
All medication comparisons